Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10.

Mowat C, Mosley SR, Namdar A, Schiller D, Baker K
J Exp Med. 2021 Sep 6;218(9). pii: 212506. doi: 10.1084/jem.20210108. Epub 2021 Jul 23. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.